Health
Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants – News-Medical.Net
A promising new study reports on the high neutralizing efficacy of a polyclonal swine antibody against SARS-CoV-2, the pathogen responsible for the novel COVID-19….
A promising new study, released as a preprint on the bioRxiv* server, reports on the high neutralizing efficacy of a polyclonal swine antibody against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the novel coronavirus disease 2019 (COVID-19). By demonstrating the ability of this antibody to neutralize all currently circulating viral variants, the study suggests that it is ideal for development as a new and very effective therapy for COVID-19.
Antibodies…
-
Noosa News17 hours agoYoung voices shape Sunshine Coast’s future
-
Business16 hours ago2 Low Cost Active ASX ETFs to consider
-
General20 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate
-
Noosa News16 hours agoQueensland government to review greenhouse gas emission reduction targets